145 related articles for article (PubMed ID: 33282721)
1. Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis.
Lian CL; Guo LY; Zhang L; Wang J; Lei J; Hua L; He ZY; Wu SG
Front Oncol; 2020; 10():522580. PubMed ID: 33282721
[TBL] [Abstract][Full Text] [Related]
2. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
3. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
Lin Y; Huang K; Zeng Q; Zhang J; Song C
PeerJ; 2020; 8():e8694. PubMed ID: 32219021
[TBL] [Abstract][Full Text] [Related]
4. Impact of Postoperative Radiotherapy on Survival of Patients With
Zhang J; Luo S; Qiu Z; Lin Y; Song C
Front Oncol; 2021; 11():625628. PubMed ID: 33816261
[No Abstract] [Full Text] [Related]
5. Prognostic value of primary tumor surgery in
Yang YS; Chen YL; Di GH; Jiang YZ; Shao ZM
Transl Cancer Res; 2019 Apr; 8(2):614-625. PubMed ID: 35116794
[TBL] [Abstract][Full Text] [Related]
6. Omission of adjuvant radiotherapy following breast-conserving surgery for elderly women with early-stage pure mucinous breast carcinoma.
Wu SG; Li FY; Wang J; Lian CL; Zhou J; He ZY
Radiat Oncol; 2019 Nov; 14(1):190. PubMed ID: 31685005
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Pattern Discriminates Survival Benefit of Type of Surgery in Patients With
Li K; Zhou C; Yu Y; Niu L; Zhang W; Wang B; He J; Ge G
Front Surg; 2021; 8():696628. PubMed ID: 34805256
[No Abstract] [Full Text] [Related]
8. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions.
Miyashita M; Balogun OB; Olopade OI; Huo D
Sci Rep; 2023 Feb; 13(1):2880. PubMed ID: 36804591
[TBL] [Abstract][Full Text] [Related]
9. Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery.
Wu SG; Zhang WW; Sun JY; Li FY; Chen YX; He ZY
Front Oncol; 2018; 8():190. PubMed ID: 29900127
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
Wu SG; Zhang WW; Sun JY; He ZY
Cancer Manag Res; 2018; 10():527-534. PubMed ID: 29593431
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients.
Cui H; Ren X; Zhao X; Dai L; Liu D; Bao Y; Hu L; Xiao Z; Ma X; Kang H
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13591-13605. PubMed ID: 37515611
[TBL] [Abstract][Full Text] [Related]
12. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer.
Lan XW; Wen G; He Z; Huang JH; Zou XB; Lin X; Tan YT; Huang XB
Cancer Manag Res; 2019; 11():6477-6487. PubMed ID: 31372049
[TBL] [Abstract][Full Text] [Related]
14. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
[TBL] [Abstract][Full Text] [Related]
15. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
Cai W; Zhuang Y; Chen J; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
[TBL] [Abstract][Full Text] [Related]
16. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
Yao Y; Chu Y; Xu B; Hu Q; Song Q
Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
[TBL] [Abstract][Full Text] [Related]
19. Noninferior Outcome After Breast-Conserving Treatment Compared to Mastectomy in Breast Cancer Patients With Four or More Positive Lymph Nodes.
Wang J; Deng JP; Sun JY; Dong Y; Zhang WW; He ZY; Wu SG
Front Oncol; 2019; 9():143. PubMed ID: 30931256
[No Abstract] [Full Text] [Related]
20. Incorporation of biologic factors for the staging of de novo stage IV breast cancer.
He ZY; Lian CL; Wang J; Lei J; Hua L; Zhou J; Wu SG
NPJ Breast Cancer; 2020; 6():43. PubMed ID: 32964117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
